文献速递生殖医学母胎医学

人类囊胚中XXY核型的患病率:来自体外受精周期植入前遗传学检测中7549例滋养外胚层活检的多中心数据

Prevalence of XXY karyotypes in human blastocysts: multicentre data from 7549 trophectoderm biopsies obtained during preimplantation genetic testing cycles in IVF.
PubMed 文献 · Hum Reprod · 2018-01-01

该多中心队列研究分析了2013年4月至2017年9月意大利六家IVF诊所2826个PGT-A周期中的7549个囊胚,发现无常染色体非整倍体的男性囊胚中47,XXY核型患病率为0.9%(17/1794)。母体年龄和囊胚质量与47,XXY核型显著相关(OR分别为1.20和1.6)。作者提出四种需进一步研究的可能解释。

要点

  • 无常染色体非整倍体男性囊胚中47,XXY核型患病率约0.9%(17/1794)。
  • 母体年龄(OR 1.20,95%CI 1.01-1.42)和囊胚质量(OR 1.6,95%CI 1.13-2.45)与47,XXY核型显著相关。
  • 该患病率高于报道的新生儿0.1-0.2%,作者提出四种需进一步研究的可能解释。

核心结论

  • 无常染色体非整倍体的男性囊胚中47,XXY核型患病率约0.9%(17/1794),高于报道的新生儿患病率0.1-0.2%,作者提出四种需进一步研究的可能情景。

研究设计与样本

  • 多中心队列研究,纳入2013年4月至2017年9月意大利六家IVF诊所2826个PGT-A周期中的7549个囊胚。
  • 囊胚行滋养外胚层活检及基于定量PCR的全染色体检测以预测相应胚胎核型。
  • 采用单因素和多因素逻辑回归分析可能混杂因素与47,XXY核型患病率的相关性。

主要发现

  • 共62个囊胚为47,XXY或XXY核型合并常染色体非整倍体。
  • 排除合并常染色体非整倍体者后,无常染色体非整倍体的男性囊胚中47,XXY核型患病率为0.9%(n=17/1794)。
  • 仅母体年龄(OR 1.20,95%CI 1.01-1.42;P=0.04)和囊胚质量(OR 1.6,95%CI 1.13-2.45;P=0.01)与47,XXY核型显著相关。

局限性

  • 这些回顾性数据基于接受IVF和PGT-A的不孕夫妇人群,女性主要为高龄。
  • qPCR技术仅验证用于检测滋养外胚层活检中的全染色体均一性非整倍体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Which is the prevalence of a 47,XXY karyotype in human blastocysts biopsied during preimplantation genetic testing for aneuploidies (PGT-A) cycles? SUMMARY ANSWER: The prevalence of a 47,XXY karyotype amongst male blastocysts without autosomal aneuploides is ~1%. WHAT IS KNOWN ALREADY: The prevalence of Klinefelter syndrome is estimated as 0.1-0.2% in male newborns. However, the KS phenotype is extremely variable and there are men with a 47,XXY karyotype and less evident signs, who may go undetected. No risk factor for the 47,XXY karyotype in products of conception has been yet clearly defined, and no data are available regarding the prevalence of this karyotype among human preimplantation embryos. STUDY DESIGN, SIZE, DURATION: This multicentre cohort study involved 7549 blastocysts obtained during 2826 PGT-A cycles performed between April 2013 and September 2017 at six IVF clinics in Italy. PARTICIPANTS/MATERIALS, SETTING, METHODS: During 2826 PGT-A cycles, 7549 blastocysts underwent trophectoderm biopsy and quantitative-PCR-based comprehensive chromosomal testing to predict the karyotype of the corresponding embryos. The results were also presented according to ranges of maternal and paternal age at oocyte retrieval as well as sperm factor and blastocyst quality. Univariate and multivariate logistic regression analyses were conducted to investigate the correlation of possible confounding factors with the prevalence of 47,XXY karyotype. MAIN RESULTS, THE ROLE OF CHANCE: Overall, 62 blastocysts were 47,XXY or had an XXY karyotype associated with autosomal aneuploidies. After exclusion of the latter, the prevalence of a 47,XXY karyotype among male blastocysts without autosomal aneuploidies was 0.9% (n = 17/1794). A significant correlation was only found for maternal age and blastocyst quality (OR: 1.20, 95% CI: 1.01-1.42; P = 0.04 and OR: 1.6, 95% CI: 1.13-2.45; P = 0.01). LIMITATIONS, REASONS FOR CAUTION: These retrospective data have been produced based on a population of infertile couples undergoing IVF and PGT-A, and the women were mainly of advanced maternal age. Moreover, the qPCR technique is validated only to detect full-chromosome uniform aneuploidies in trophectoderm biopsies. WIDER IMPLICATIONS OF THE FINDINGS: The 0.9% prevalence of the 47,XXY karyotype among male blastocysts, when compared with the 0.1-0.2% prevalence reported in the prenatal and postnatal periods, suggests four possible scenarios that require further investigations: (i) the latter prevalence is underestimated; (ii) 47,XXY blastocysts result in a lower implantation rate than euploid embryos (estimated to be ≈50%); (iii) 47,XXY blastocysts result in a higher early miscarriage rate than euploid embryos (estimated to be ≈10%); or (iv) infertile patients of advanced maternal age and referred to IVF/PGT-A produce a higher rate of 47,XXY blastocysts. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Mazzilli R, Cimadomo D, Rienzi L, et al. Prevalence of XXY karyotypes in human blastocysts: multicentre data from 7549 trophectoderm biopsies obtained during preimplantation genetic testing cycles in IVF. Hum Reprod. 2018. PMID: 29788175. doi:10.1093/humrep/dey110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。